A demonstration of the Cocoon® platform: a bespoke solution to minimize manual touchpoints in cell therapy manufacturing

Cell & Gene Therapy Insights 2021; 7(3), 389

10.18609/cgti.2021.064

Published: 21 April 2021
FastFacts
Joseph O’Connor


Watch the demonstration video or read the poster to learn how the Cocoon® platform streamlines patient-scale cell therapy manufacturing by minimizing manual touchpoints at every stage:

  • Sample loading
  • Activation
  • Transduction or transfection
  • Expansion
  • Harvest

About the speaker

Joseph O’Connor, PhD, is currently a senior scientist in process development for Lonza’s Personalized Medicine Business Unit. His focus is on translating and optimizing manual autologous cell therapies into the Cocoon® Platform, a closed and automated cell therapy manufacturing solution. Joseph earned a doctorate in chemical engineering from the Pennsylvania State University while researching the mechanical regulation of gene expression. He has been with Lonza since 2017.